Congressman Tim Ryan Announces Nearly $1M for Cancer Research and $300K for DNA Research at Kent State University
Kent, Ohio — Congressman Tim Ryan (OH-13) today is announcing a total of $1.2 million in grant funding for Kent State University for cancer and DNA research. The University is receiving two grants from the U.S. Department of Health and Human Services (HHS), the first in the amount of $445,431 for cancer treatment research and the second grant of $454,646 for cancer detection and diagnostic research. An additional grant of $300,000 is being awarded to Kent State by the National Science Foundation for DNA research into membrane proteins, which is fundamental research into the behavior of cells and how drugs interact with the cell surface to treat many diseases, including cancer.
"I am proud of the commitment that Kent State University has made to research, especially to the important work being done to find detection and treatment therapies for cancer,” said Congressman Ryan. “I will always support these types of federal investments that help make those advances possible.”
“These highly competitive federal awards speak to the excellence of the biomedical and biophysical research being conducted by Kent State University faculty,” said Paul DiCorleto, Ph.D, Vice President of Research and Sponsored Programs at Kent State University. “These projects by Professors Manabu Kurokawa, Yaorong Zheng, and Thorsten Schmidt will advance fundamental knowledge about cellular behavior and examine new ways that cancer may develop and novel therapeutics to treat the disease.”
In 1937, Congress passed legislation establishing the National Cancer Institute (NCI) as the federal government's primary agency to address research and training needs for the cause, diagnosis, and treatment of cancer. The National Science Foundation (NSF) is an independent federal agency created by Congress in 1950 to promote the progress of science and advance national health, prosperity, and welfare.